Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model-Reference-Cited by-同舟云学术

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model

Published:2010-03 Issue:6 Volume:79 Page:880-887
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Liu Jun-Yan,Yang Jun,Inceoglu Bora,Qiu Hong,Ulu Arzu,Hwang Sung-Hee,Chiamvimonvat Nipavan,Hammock Bruce D.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference63 articles.

1. Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation;Levick;J Immunol,2007

2. The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain;Sciulli;Pharmacol Rep,2005

3. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer;Claria;Curr Pharm Des,2005

4. Heart disease. Gene suggests asthma drugs may ease cardiovascular inflammation;Wickelgren;Science,2004

5. Five-lipoxygenase pathway of arachidonic acid metabolism in carcinogenesis and cancer chemoprevention;Chen;Curr Cancer Drug Targets,2006

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular hybridization: a powerful tool for multitarget drug discovery;Expert Opinion on Drug Discovery;2024-03-08

2. Protective effect of clotrimazole on lung injury in an experimental model of ruptured abdominal aortic aneurysm;Advances in Clinical and Experimental Medicine;2024-02-27

3. Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches;Frontiers in Endocrinology;2024-02-15

4. Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD;Journal of Allergy and Clinical Immunology;2023-11

5. Novel thiazolopyridine derivatives of diflapolin as dual sEH/FLAP inhibitors with improved solubility;Bioorganic Chemistry;2023-10